| Indicator | Current Period | YoY | YoY |
|---|---|---|---|
| Revenue | ¥21.7B | ¥19.6B | +10.7% |
| Operating Income | ¥1.5B | ¥1.4B | +1.5% |
| Ordinary Income | ¥1.6B | ¥1.6B | +3.8% |
| Net Income | ¥1.1B | ¥1.1B | +5.2% |
| ROE | 4.8% | 4.8% | - |
FY2026 Q3 results were: Revenue ¥21.7B (YoY +¥2.1B +10.7%), Operating Income ¥1.5B (YoY +¥0.02B +1.5%), Ordinary Income ¥1.6B (YoY +¥0.06B +3.8%), and Net Income ¥1.1B (YoY +¥0.05B +5.2%). Revenue achieved double-digit growth, with top-line expansion lifting each profit layer. Gross profit margin remained high at 37.3%, while SG&A was ¥6.6B, resulting in an operating margin of 6.8%; however, contributions from non-operating income supported stable growth from Ordinary Income downward. Full-year guidance calls for Revenue of ¥30.0B (YoY +11.1%), Operating Income of ¥2.0B (YoY +0.7%), Ordinary Income of ¥2.0B (YoY +1.3%), and Net Income of ¥1.4B (YoY +0.3%), with progress tracking well.
[Profitability] ROE 4.8% (DuPont: Net Profit Margin 5.2% × Asset Turnover 0.79x × Financial Leverage 1.18x), Operating Margin 6.8%, Gross Profit Margin 37.3%. Versus revenue growth of +10.7%, Operating Income growth was +1.5%, indicating limited operating leverage. [Cash Quality] Cash and deposits of ¥19.7B account for 71.8% of total assets; cash coverage of short-term liabilities of ¥4.1B is 4.8x. Working capital is ¥21.0B, providing ample liquidity. [Investment Efficiency] Asset Turnover is 0.79x, with a high cash ratio suppressing turnover. EPS is ¥53.81, and with a dividend of ¥10.00, the calculated Payout Ratio is approximately 19.6%. [Financial Soundness] Equity Ratio is 84.4% (improved from 81.0% YoY), Current Ratio 618.6%, and Debt-to-Equity Ratio 0.18x, indicating a highly conservative financial profile.
Cash and deposits increased slightly from ¥19.6B to ¥19.7B, maintaining a high level of on-hand liquidity. Total assets rose marginally from ¥27.3B to ¥27.4B (+¥0.1B), with no evidence of aggressive capital expenditures or asset acquisitions. Based on balance sheet trends, profit retention from higher operating profits appears to have funded dividends and expenses, sustaining cash levels. Current assets are ¥25.1B, providing over 6x coverage of current liabilities of ¥4.1B and ensuring robust short-term solvency. Advances received of ¥1.8B and prepaid expenses of ¥1.6B are included in working capital, suggesting room to enhance cash efficiency through receivables and payables management. Intangible fixed assets decreased from ¥0.5B to ¥0.4B, down ¥0.1B (-22.7%), indicating a recovery phase for software amortization and similar investments. Cash generation is solid, but execution of capital allocation options (growth investments, M&A, enhanced shareholder returns) will be key to improving capital efficiency.
Ordinary Income is ¥1.6B versus Operating Income of ¥1.5B, implying a net increase from non-operating items of about ¥0.1B. Non-operating income is ¥0.2B and non-operating expenses are ¥0.02B; the breakdown of non-operating income is presumed to include financial income such as interest and dividends received. Non-operating income is 0.8% of revenue and small in scale, with core operating profit comprising the bulk of earnings. Against Profit Before Tax of ¥1.6B, Net Income after tax effects is ¥1.1B, for an effective tax rate of 31.9%, which is standard. On-hand cash is ample, cash generation aligns with the level of net profit, and earnings are well supported by cash. From an accrual perspective, working capital is tracking at similar levels to the prior year, with no sharp buildup in receivables or inventories; the quality of earnings can be assessed as sound.
Risk of rising SG&A: SG&A of ¥6.6B accounts for 30.5% of revenue; while revenue grew +10.7%, Operating Income growth was limited to +1.5%. If personnel and marketing expenses are on an upward trend, operating leverage may fail to materialize and the operating margin could decline. Absence of growth investment risk: Although holding ¥19.7B in cash and deposits (71.8% of total assets), capital expenditures and investments in intangible assets are limited, and capital efficiency (ROE 4.8%) significantly underperforms the industry median of 9.7%. Without concrete plans for deploying funds, enhancement of shareholder equity value may be constrained. FX and market volatility risk: As financial income is included in non-operating income, results may be affected by interest rate and foreign exchange fluctuations. During periods of sharp market moves, non-operating gains/losses may fluctuate, impacting Ordinary Income.
[Position within Industry] (Reference information, in-house survey) Profitability: ROE 4.8% (4.9pt below the industry median of 9.7%), Operating Margin 6.8% (1.4pt below the industry median of 8.2%), Net Profit Margin 5.2% (in line with the industry median of 5.7%). Soundness: Equity Ratio 84.4% (+35.4pt above the industry median of 49.0%, placing the company in the upper tier), Current Ratio 618.6% (significantly above the industry median of 206%). Growth: Revenue growth rate +10.7% (+1.2pt above the industry median of +9.5%). Efficiency: Asset Turnover 0.79x, where the high cash holding ratio suppresses turnover, and Return on Assets (calculated value 4.1%) is slightly below the industry median of 4.7%. The company ranks among the top in financial soundness within the industry, but capital efficiency and profitability are below the industry median, making effective use of cash on hand a key issue. (Industry: Healthcare, comparison set: 44-company median for Q3 2025, source: in-house aggregation)
Sustainability of revenue growth and room for margin improvement: Revenue has achieved double-digit growth for two consecutive years, and progress toward full-year guidance is favorable. Meanwhile, the operating margin of 6.8% is below the industry median of 8.2%, indicating room for improvement if SG&A efficiency (digitalization and process optimization) advances. Cash holdings and capital allocation strategy: Cash and deposits of ¥19.7B account for 71.8% of total assets, indicating extremely high financial soundness, but capital efficiency remains low with ROE at 4.8% (industry median 9.7%). Executing any of growth investments (M&A/new businesses), share buybacks, or dividend increases could contribute to enhancing shareholder value. Dividend sustainability and capacity for shareholder returns: With a Payout Ratio of 19.6% and a dividend of ¥10.00, distributions are sustainable in light of cash generation and net profit levels. Given strong cash on hand, there is room for dividend increases, and disclosure of future capital allocation policies bears watching.
This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not constitute a recommendation to invest in any specific security. Industry benchmarks are reference information aggregated by our company based on publicly available financial statements. Investment decisions are your own responsibility; consult a professional as necessary before making any investment decisions.